Athena Diagnostics Quest Diagnostics Win in Wrongful Death Case Reveals Ongoing Challenges for Variant Classification Williams v Quest/Athena struck a nerve with the genetic testing community by probing what the standard of care is and ought to be for variant classification. Mayo Tells Supreme Court Congress Should Clarify Patent Eligibility Confusion in Diagnostics Premium Athena and its supporters have asked the Supreme Court to clarify patent eligibility, but Mayo recently countered that this is a job for legislators. Quest Diagnostics Wrongful Death Lawsuit Ordered to Move to Discovery The development is a positive for plaintiff Amy Williams, who has said she hopes her lawsuit will spur greater accountability and transparency among genetic testing labs. In Williams v Quest, State Supreme Court Leaves Room for Plaintiff to Argue Ordinary Negligence Though the South Carolina Supreme Court said Quest was a healthcare provider, Williams can try to keep her case alive by arguing she's alleging ordinary negligence. South Carolina Supreme Court Mulls Whether Quest is Healthcare Provider in Wrongful Death Suit The court's determination is critical to deciding if Williams v Quest/Athena can advance or if it must be dismissed on statute of repose grounds. Nov 27, 2017 Labs Confront Legal Risks Posed by Genetic Variant Classification, Reporting Premium Apr 4, 2017 Wrongful Death Suit Awaits Input From South Carolina Supreme Court Jan 6, 2017 In Quest/Athena Wrongful Death Suit, District Court Judge Holds Hearing on Motion to Dismiss Oct 24, 2016 NAS Committee Input on Genetic Variant Data Sharing Could Make it Standard Practice, Experts Say Oct 24, 2016 National Academies Committee Considering Liability Issues for Labs Grappling With Genetic Variation Aug 15, 2016 Quest, Athena Reply to Plaintiffs in Wrongful Death Lawsuit Jul 26, 2016 Plaintiffs Counter Quest/Athena Motion to Dismiss Wrongful Death Lawsuit With New Affidavit Jun 27, 2016 Quest, Athena File Another Motion to Dismiss Amended Wrongful Death Complaint May 16, 2016 Plaintiffs Argue Against Quest, Athena's Motion to Dismiss Negligence Case Apr 5, 2016 Quest, Athena File Motion to Dismiss Negligence Suit Apr 1, 2016 Quest, Athena Make Moves in Wrongful Death Lawsuit Mar 14, 2016 Mother's Negligence Suit Against Quest's Athena Could Broadly Impact Genetic Testing Labs Mar 10, 2015 Quest's Athena Dx, Personalis Launch Diagnostic Exome for Neurological Disorders Premium Jun 19, 2013 Innovation Boom or Bust? Industry Gauges Impact of SCOTUS Ruling on Gene Patents Premium Mar 20, 2013 Quest's Athena Diagnostics Launches NGS Panel Test for Charcot-Marie-Tooth Disease Premium Mar 20, 2013 New Products: SoftGenetics' Geneticist Assistant; Ariosa's Harmony Test; Quest's CMT Panel; More Premium Jan 16, 2013 Hearing on Second-Opinion Genetic Testing Highlights Risks of Athena's Exclusive Licensing Practices Premium Dec 11, 2012 Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests Premium Nov 11, 2011 Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing Apr 27, 2011 Duke University Keeping an Eye on DTC Genomics Firms that Might be Infringing its APOE Patents Premium Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.